1-12 of 12
Jennifer Dumont
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unmet Needs, Factor Consumption, and Healthcare Resource Use Among People with Hemophilia a: Real-World Analysis of the Adelphi Hemophilia Disease Specific Programme TM

Free
Lynn Malec, Davide Matino, Kieran Wynne-Cattanach, Chris Blazos, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi, Jennifer Dumont
Journal: Blood
Blood (2024) 144 (Supplement 1): 3973.
https://doi.org/10.1182/blood-2024-193803
Published: 2024
Journal Articles

Real-World Experience of Switching to Prophylactic Efanesoctocog Alfa in Patients with Moderate and Severe Hemophilia a: An Analysis of the Adelphi Hemophilia Wave III Disease Specific Programme

Free
Maissaa Janbain, Miguel A. Escobar, Manuel Carcao, Andrew Wilson, Jennifer Dumont, Nathan Ball, Ella Morton, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi
Journal: Blood
Blood (2024) 144 (Supplement 1): 131.
https://doi.org/10.1182/blood-2024-193764
Published: 2024
Journal Articles

Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study

Free
Robert Klamroth, Stephanie P'ng, Sophie Susen, Davide Matino, Pratima Chowdary, Angela C Weyand, Toshko Lissitchkov, Young-Shil Park, María Teresa Alvarez-Román, Liqi Feng, Helena Palmborg, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Keiji Nogami
Journal: Blood
Blood (2024) 144 (Supplement 1): 717.
https://doi.org/10.1182/blood-2024-204533
Published: 2024
Journal Articles

Experiences with Efanesoctocog Alfa: Exit Interviews with Caregivers of Previously Treated Patients with Hemophilia A from the XTEND-Kids Phase 3 Clinical Trial

Free
Lynn Malec, Manuel Carcao, Mary Mathias, Nana Kragh, Jennifer Dumont, Annemieke Willemze, Linda Bystrická, Amanda Wilson, Dana Dibenedetti
Journal: Blood
Blood (2023) 142 (Supplement 1): 507.
https://doi.org/10.1182/blood-2023-181973
Published: 2023
Journal Articles

Experience with Accelerometer Physical Activity Tracking in Adults and Adolescents with Hemophilia A: Tool Validation Using Results from the XTEND-1 Efanesoctocog Alfa Phase 3 Trial

Free
Amanda Wilson, Jérôme Msihid, Nicolai Ayasse, Jennifer Dumont, Annemieke Willemze
Journal: Blood
Blood (2023) 142 (Supplement 1): 2360.
https://doi.org/10.1182/blood-2023-179751
Published: 2023
Journal Articles

Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study

Free
Clinical Trials & Observations
Lynn Malec, An Van Damme, Anthony K. C. Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi
Journal: Blood
Blood (2023) 141 (16): 1982–1989.
https://doi.org/10.1182/blood.2022017780
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy of Efanesoctocog Alfa on Pain in Patients with Hemophilia A: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Free
Amanda Wilson, Nana Kragh, Jerome Mshijid, Jennifer Dumont, Annemieke Willemze, Elena Santagostino, Chuanwu Zhang, Roshni Kulkarni, Annette von Drygalski, Pratima Chowdary
Journal: Blood
Blood (2022) 140 (Supplement 1): 5610–5611.
https://doi.org/10.1182/blood-2022-166849
Published: 2022
Journal Articles

Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Free
Amanda Wilson, Nana Kragh, Jennifer Dumont, Jerome Mshijid, Annemieke Willemze, Linda Bystricka, Chuanwu Zhang, Angela C. Weyand, Kathelijn Fischer, Victor Jimenez-Yuste
Journal: Blood
Blood (2022) 140 (Supplement 1): 5595–5596.
https://doi.org/10.1182/blood-2022-167542
Published: 2022
Journal Articles

Efficacy of rFVIIIFc for First-Time Immune Tolerance Induction (ITI) Therapy: Final Results from the Global, Prospective VerITI-8 Study

Free
Lynn Malec, An Van Damme, Anthony Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi
Journal: Blood
Blood (2021) 138 (Supplement 2): LBA-5.
https://doi.org/10.1182/blood-2021-155156
Published: 2021
Journal Articles

Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies

Free
Janice M. Staber, Toshko Lissitchkov, Barbara A. Konkle, Amy D. Shapiro, Doris V. Quon, Roshni Kulkarni, Melinda Hamilton, Ekta Seth Chhabra, Suresh Katragadda, Arman Altincatal, Annemieke Willemze, Jennifer Dumont, Margaret V. Ragni
Journal: Blood
Blood (2021) 138 (Supplement 1): 1035.
https://doi.org/10.1182/blood-2021-148534
Published: 2021
Journal Articles

Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure

Free
Manuel Carcao, Amy Shapiro, Nina Hwang, Steven Pipe, Sanjay Ahuja, Kenneth Lieuw, MD PhD, Janice Staber, Haowei Linda Sun, Hilda Ding, Michael Wang, Macgregor Steele, Elisa Tsao, Jing Feng, Zahra Al-Khateeb, Jennifer Dumont, Nisha Jain
Journal: Blood
Blood (2018) 132 (Supplement 1): 2500.
https://doi.org/10.1182/blood-2018-99-110467
Published: 2018
Journal Articles

Extravascular Distribution of Conventional and Ehl FIX Products Using In Vivo SPECT Imaging Analysis in Hemophilia B Mice

Free
Joe Salas, PhD, Arjan Van Der Flier, PhD, Vu P. Hong, PhD, Jennifer Dumont, PhD, Kelly D Orcutt, PhD, Apollina Goel, PhD, Robert Peters, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1061.
https://doi.org/10.1182/blood.V130.Suppl_1.1061.1061
Published: 2017